Money Maker
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Deal is closed and sitting on a small pile of cash + 14mil market cap = $$$$$$
All IMO...
$GBLX
OTC Stock Review Features Four CBD Stocks for 2020
10:25 am ET November 21, 2019 (Globe Newswire) Print
CBD products are becoming extremely popular as consumers discover the benefits of cannabidiol in industries like cosmetics, health products, food and beverage, pet products, skin care, and pharmaceuticals. According to BDS Analytics and Arcview Market Research, the collective market for CBD sales is expected to exceed $20 billion in the United States by 2024. According to a recent Gallup Poll, 14% of Americans say they use CBD based products. This could add up to explosive growth potential for companies like Canbiola, Inc. (OTCQB: CANB), GB Sciences, Inc. (OTCQB: GBLX), General Cannabis Corp. (OTCQX: CANN), and Curaleaf Holdings Inc. (OTCQX: CURLF).
Canbiola, Inc. (OTCQB: CANB) announced better than expected third quarter financial results for the period ended September 30, 2019. Revenues for Q3 2019 increased 277% to $615,422 from Q3 2018. Gross margin also increased to 77% for the quarter.
During Q3 2019, Canbiola closed on a joint venture with NY SHI and Shi Farms to operate the NY Hemp Depot facility in New York. Shi Farms operates a 300-acre farm and 40,000 square feet of research greenhouses in Colorado. Since Canbiola typically buys 150+ kilos of isolate per year, this joint venture will enable the Company to save thousands of dollars per kilo via reduced processing fees. Also in Q3 2019, Canbiola launched its Canbiola-branded CBD dispensing machine, which will place Canbiola's Branded CBD products in MRI locations, outpatient surgery centers, urgent care, physician offices, and even golf clubhouses.
Canbiola targets consumers through retail and internet channels with its Pure Leaf Oil and Seven Chakras product line. The Canbiola brand and product line is marketed through the medical professionals' market. Canbiola products are made from all-natural ingredients and processed and packaged by state-of-the-art equipment in a "clean room" environment.
Other cannabis-related developments from around the markets include:
GB Sciences, Inc. (OTCQB: GBLX) completed the sale of its 50% membership interest in GB Sciences Louisiana, LLC to Wellcana Plus, LLC, an affiliate of Wellcana Group, LLC who owns the other 50% interest on November 15, 2019. The sale immediately eliminates current cash obligations due from GB Sciences as well as the Company's share of operating expenses going forward.
General Cannabis Corp. (OTCQX: CANN) announced it entered into a contract for the sale of its Greenhouse Office building in Denver, Colorado for $1,697,500. General Cannabis acquired the property in 2014 for $1,050,000.
Curaleaf Holdings Inc. (OTCQX: CURLF) reported a narrower-than-expected loss, but revenue that fell short of consensus estimates. The cannabis retailer reported a third-quarter net loss of $6.8 million or a penny a share, versus losses of $33.7 million, or 9 cents a share in the year-ago period. Revenue rose to $61.8 million from $21.4 million. Analysts polled by FactSet had expected losses of 2 cents a share on revenue of $61.8 million. Analysts expect fourth-quarter revenue of $101.1 million.
I see that you forgot to take your meds again...
$GBLX
Bottom line... spewing random speculation...
$GBLX
No doubt something leaked out... Could be sale related...
Deal closed = small pile of cash...
All IMO...
$GBLX
you and I been here along time tracking this...gotta know what you own...that's what it comes down to.
They will crush earnings on Monday IMO... moving today on decent volume... that dip below $4.00 was a gift... you can see by how organized and textbook the trading has been that the larger powers that be are in control here...
Big short position on this one... a squeeze can easily take this 25% - 50% higher...
Market Cap 170.5M / Shares Outstanding 35.5M... 11/11/19 Q3 2019 GrowGeneration Corp Earnings Release - Estimate: $0.025... Damn those numbers look tasty...
This stock is hands down my top 2019 pick in the 420 arena...
All IMO...
I don't believe so... there is no notation stating that in the piece... by all means, correct me if I'm wrong...
Here are the related links....
https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14674016/we-expect-accelerated-growth-lake-street-sees-perfect-cannabis-play-in-growgenerati
https://finance.yahoo.com/news/expect-accelerated-growth-lake-street-215208034.html
$GRWG
I can't believe people are still buying this garbage... Damn, they split this and crushed their investors... I guess $ERBB will continue to fleece uninformed buyers until the SEC shuts them down...
As far as anyone looking to dive in to this stock... $ERBB is a dumpster fire where millions of dollars have been incinerated by managements pockets... buyer beware... there are many solid beat down cannabis plays out there... run from this one as fast as you can...
All IMO...
$ERBB
'We Expect Accelerated Growth': Lake Street Sees Perfect Cannabis Play In GrowGeneration
GrowGeneration Corp. (OTC: GRWG) shares are up 54.34% year-to-date.
The Analyst
Lake Street Capital Market’s Mark Smith initiated coverage of GrowGeneration with a Buy rating and $6.50 price target.
The Thesis
Demand for cannabis products is rising, creating new opportunities for GrowGeneration, a supplier of growing equipment, Smith said in the Monday initiation note. (See his track record here.)
The analyst compared an investment in GrowGeneration to investments in Tractor Supply Company (NASDAQ: TSCO) or Pool Corp. (NASDAQ: POOL) at similar stages in their development, adding that both companies have been growth stock winners over a long period of time.
Investors have been missing the following points about GrowGeneration, Smith said:
Consolidation Opportunity: GrowGeneration has advanced its business via acquisitions, and the analyst said it's possible the company will continue to consolidate and take share.
Impressive Unit Returns: “The company has two primary means for unit growth, acquisitions and new store openings, and both provide strong cash-on-cash returns for shareholders.”
Evolving Retail Strategy: The company has been experiencing growth in online sales, and through a partnership with Amazon.com, Inc. (NASDAQ: AMZN) and improvements of its pickup and drop-ship capacities, it can turn into an omnichannel retailer, according to Lake Street.
Economies Of Scale Should Boost Profitability: “The company shifted to positive EBITDA in early 2019 and we project EBITDA margin of 8% in 2019 will grow to 10.6% in 2020 and can continue into the mid-teens as the company leverages corporate overhead and gains scale in purchasing and marketing.”
GrowGeneration is a dominant player in the hydroponic supply industry, with huge growth potential, Smith said.
“The company has approximately doubled its revenue annually for the last two years and we expect accelerated growth in 2019. Additionally, the company has produced positive EBITDA the last two quarters and we expect the company to remain cash flow positive going forward.”
Price Action
The stock was up 9.07% at $4.21 at the close Monday.
Related Links:
Former Home Depot CEO Joins GrowGeneration As A Strategic Advisor
GrowGeneration Closes .8M Private Placement
Apha earnings... micro ... cannabis 2.0... edibles and banking catalyst... macro...
Keeping it real... all IMO...
$MJ
Acquisition rumors have been swirling for months... lots of propaganda spread on Twitter...
National Access Cannabis Corp. Generates Over $60 Million in Retail Sales in the First Year Since Federal Legalization at a Cumulative Gross Margin of 32%.
https://www.newswire.ca/news-releases/national-access-cannabis-corp-generates-over-60-million-in-retail-sales-in-the-first-year-since-federal-legalization-at-a-cumulative-gross-margin-of-32-i--839926595.html
$NACNF
Firming up... it's been a wild ride down to the basement... locked and loaded!... capital appreciation aside, this is a buy just for the divi at this price point...
All IMO...
$MJ
Same here... Locked and loaded... been accumulating over the past few weeks... downside at this point is extremely limited... upside is huge...
All IMO...
$YOLO
Anything under $4.00 is a gift...
At this level you're splitting hairs with your "Sure thing,is that why it's going to $3.50??????"... the reality is that a nice base has been forming... all part of the bottoming process and trading... heading higher my friend... $4.00 a stone throw away... hope you took advantage...
GL to you...
All IMO...
$GRWG
Happy Cannabis 2.0... Trade on...
$MJ...
Cannabis stocks slammed as MedMen abandons deal and Aleafia drops Aphria as supplier. Cannabis ETFs down more than 2% as broader market falls and vaping-related illness unsettles investors.
https://www.marketwatch.com/story/cannabis-stocks-slammed-as-medmen-abandons-deal-aleafia-drops-aphria-as-supplier-2019-10-08?siteid=yhoof2&yptr=yahoo
You're so off my friend... Google vaping... CannTrust & cannabis earnings... all priced in for the time being...
All IMO...
$MJ...
Solid day going into the close... real nice bump off the low... if we close around this level... the weekly candle sets us up...
All IMO...
$MJ...
I think we get that...
$MJ....
Chart reset... ready for the next push higher... $6-7 next move...
All IMO...
$GRWG
HOD going into the close... the golf ball is on the tee!...
$MJ
Really strong 2 days... trend reversal or dead cat bounce?...
$MJ
Ya... a day late... oh well... $20.16 print yesterday wasn't bad... Short covering going on... big moves in some of the beat down names... Volume is up... if we can hold these gains, trade on!...
All IMO...
$MJ...
Buy target reached... also added a few more today... where we go from here is anyones guess...
$MJ...
There's a reason why Nardelli is on board... executives of his caliber don't manage losers...
All IMO...
$GRWG
Anyone shorting the sector at this point needs their head examined... just sayin'...
All IMO
$MJ...
Ontario Cannabis Changes Could See Pot Stocks Rocket
https://www.msn.com/en-us/finance/news/ontario-cannabis-changes-could-see-pot-stocks-rocket/ar-AAI4t9F
Looks like a trading bottom is forming... Sellers exhausted... short covering coming...
All IMO...
$MJ
Back in Doc!... Took a nibble and jumped in on a trade today... bought 420 ETF's across the board... At these prices, short-term downside is extremely limited... reward outweighs risk significantly... could possible trade down slightly... willing to take that gamble with Cannabis 2.0 on the horizon and Banking news...
All IMO...
$THCX
October if you're short... Lets hope we don't repeat the last few... New years, spring & summer have been most profitable for long investors... crushed in October going into the new year...
Bought a few across the 420 ETF board today... like the way the candles are setting up for a trade... short-term downside risk IMO is a buck and change with this one... 50 day MA sitting at 25.83, RSI in the teens... a trade up to $24 area is doable before traders take profit (still think we could trade down... however willing to gamble at this price point)... all contingent upon a BIG IF... if we trade higher...
All IMO...
$MJ
Short sellers in conjunction with stops triggered and profit takers...
The entire sector is under extreme pressure for a multitude of reasons... $GRWG is no exception to feeling that pressure... all ships rise and fall with the tide...
All IMO...
$GRWG
Agree... and it looks like it's it's staying there a little longer... Damn... banking didn't even move this higher... scary... the vape mystery is a very big deal for both nicotine and THC based products... lots of pressure on extracts... IMO $20.00 is inevitable... recent negative headlines will be priced in at that level... just hope we don't get another curve ball... no telling how far this trades down on additional negative news...
Bottom line... glad I held back from nibbling yesterday...
All IMO...
$MJ
House passes bill that would allow banks to work with cannabis companies.
By a vote of 321-103, lawmakers approved the bill, which now heads to the Senate. The bill received nearly unanimous support from Democrats, as well as nearly half of all Republicans.
https://news.yahoo.com/house-passes-bill-allow-banks-222648672.html
$THCX
Just saw that... huge step forward... lets hope this is the catalyst we need to put a bottom in...
House passes bill that would allow banks to work with cannabis companies.
By a vote of 321-103, lawmakers approved the bill, which now heads to the Senate. The bill received nearly unanimous support from Democrats, as well as nearly half of all Republicans.
https://news.yahoo.com/house-passes-bill-allow-banks-222648672.html
Trading bounce coming... easy trade up... need a solid bottom put in place for trend reversal... not quite there yet...
All IMO...
$THCX
Show us the money $ALEAF... all talk until their bottom line is green... pretty much like that across the board at this point...
Lots of disappointments, downward revisions and straight up scams... $ALEAF is no exception... stay of execution with this PR... investors should have their fingers crossed...
All IMO...
$ALEAF
Cannabis investing enthusiasts now have a sixth exchange traded fund to consider following the Thursday debut of the Global X Cannabis ETF (NASDAQ: POTX).
POTX tracks the Cannabis Index, making it the third passively managed fund in the cannabis ETF space.
What Happened
Measuring the success of the U.S.-listed cannabis beyond the ETFMG Alternative Harvest ETF (NYSE: MJ), the group's largest and oldest fund, is difficult at this point because, including POTX, five of those six ETFs have come to market since April of this year.
Specific to POTX, its issuer, Global X, is not only a well-known ETF sponsor, but one that has proven adept in the field of thematic funds, amassing impressive assets under management tallies with ETFs offering exposure to an array of investment niches, such as cloud computing, fintech, social media and many more.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
Why It's Important
POTX debuts with 24 stocks on its roster and like many of its competitors, the fund is heavily exposed to Canadian cannabis companies (81.14% of the new ETF's weight).
“In October 2018, Canada achieved a milestone as the first G-7 country to fully legalize adult use of recreational cannabis,” according to Global X research. “Since then, cannabis consumption has been on the rise, with 17.5% of Canadians reporting use, up from 14% a year ago, prior to legalization.In addition, sales of various medical and non-medical forms of cannabis increased 53% in the aggregate less than a year since recreational use was first allowed.”
Well-known Canadian cannabis names in POTX include Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB) and Cronos Group (NASDAQ: CRON).
One advantage POTX has is that with an annual fee of 0.50%, or $50 on a $10,000 investment, it's the second-cheapest marijuana ETF. At 0.42% per year, only the Cambria Cannabis ETF (CBOE: TOKE) is cheaper.
What's Next
Integral to POTX's long-term fortunes and those of its passive rivals will be the ability of Canadian cannabis firms to gain footholds in the fast-growing, likely more lucrative U.S. market. California is the largest state in the union and has fully legalized marijuana, but the state's onerous tax systems has kept its cannabis black market alive and well, prompting many industry observers to cite Colorado as the template weed success in the U.S.
“Since allowing recreational retail distribution of cannabis in 2014, Colorado’s monthly sales figures offer more recent insights into the potential growth trajectory of newly legalized markets,” said Global X. “Recreational sales started at $14 million per month in 2014, growing to over $122 million by June 2019, representing a 48% compound annual growth rate (CAGR). In June 2019, Colorado reached combined monthly recreational and medical sales of $152 million, or a $1.8 billion annual revenue run rate.Total sales since legalization stand at roughly $6.8 billion.”
If the number of states, currently 11, with fully legal marijuana increases and Canadian companies prove adept at encroaching into the U.S., POTX could be a winner.
$CVSI future earnings uncertain and "choppy"... you understand?... supply outweighing demand... you understand?... pricing pressure... you understand?... increased competition... you understand?... wolf needs a reality check... you understand?
$CVSI